NovoCure(DE:038)
€10.66+0.32 (+3.10%)
DE:038
NovoCure earnings date
€10.66
At close:+0.32 (+3.10%)
NovoCure (038) Q3 2022 Earnings Report
4 Followers
DE:038 Q3 2022 EPS Results
- Actual EPS
- -EUR 0.23
- Consensus EPS
- -EUR 0.24
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.12
DE:038 Q3 2022 Revenue Results
- Actual Revenue
- EUR 118.41M
- Expected Revenue
- EUR 118.06M
- Beat/Miss
- Beat by +EUR 351.63K
- YoY Revenue Growth
- -1.95%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 10/27/2022
- Time
- Before Open
- Conference Call
- Thursday, October 27, 2022
DE:038 Upcoming Earnings
NovoCure's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
DE:038 Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:038 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.19- | -0.2 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.21-0.08 | -0.3 | 72.73% (+0.22) | |
| Jul 23, 2026 | 2026 (Q2) | -0.30-0.12 | -0.33 | 63.89% (+0.21) | |
| Apr 30, 2026 | 2026 (Q1) | -0.46-0.56 | -0.28 | -100.00% (-0.28) | |
| Feb 26, 2026 | 2025 (Q4) | -0.37-0.20 | -0.55 | 63.93% (+0.35) | |
| Oct 30, 2025 | 2025 (Q3) | -0.38-0.30 | -0.25 | -17.86% (-0.05) | |
| Jul 24, 2025 | 2025 (Q2) | -0.35-0.33 | -0.28 | -16.13% (-0.05) | |
| Apr 24, 2025 | 2025 (Q1) | -0.42-0.28 | -0.33 | 13.89% (+0.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.31-0.55 | -0.41 | -35.56% (-0.14) | |
| Oct 30, 2024 | 2024 (Q3) | -0.30-0.25 | -0.42 | 39.13% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
